Life sciences executive named to national NAMB Board see more
Nephron Pharmaceuticals Corporation today announced CEO Lou Kennedy as a new member of the National Association of Manufacturers Board of Directors.
Kennedy, who was elected on Monday, joins the NAM Board to bolster the association’s leadership in policy advocacy, workforce solutions, legal action, operational excellence and news and insights. She will help the industry advance an agenda that promotes growth and prosperity for all Americans.
“I could not be more excited and honored to join the board,” said Kennedy. “Our team has been fortunate to work with NAM over the last few years on critical issues, from COVID-19 to workforce development, and we are always impressed by the results NAM delivers for its members, as well as for employers and employees across the nation.”
NAM and its members are at the forefront of every important policy debate for manufacturers and have led the nation’s response to COVID-19.
Board members play a key role in the NAM’s “Creators Wanted” campaign, a member-driven initiative to inspire and drive more Americans to pursue careers in modern manufacturing.
“Lou Kennedy is a recognized leader in our industry, and the NAM will be stronger thanks to her service on our Board of Directors,” said NAM President and CEO Jay Timmons. “Manufacturers are the driving force behind our economic recovery and our fight to defeat COVID-19. We are working with lawmakers to ensure they deliver the relief America needs and the long-term policy work on issues like infrastructure investment, immigration reform, trade expansion and workforce development. We will also defend the progress we’ve made on tax reform and regulatory certainty to ensure we can keep our promises to invest in our people and communities and build the strongest economy possible. The NAM’s mission is to ensure we always keep moving forward, and Lou will bring invaluable insights as we advocate for the men and women of our industry and advance the values that have made America exceptional and our industry strong — free enterprise, competitiveness, individual liberty and equal opportunity.”
A West Columbia, S.C.-based company, Nephron is a nationwide leader in the development and production of safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. The company recently opened a CLIA-certified diagnostics lab, conducts COVID-19 tests and administers vaccines. Nephron announced a new $215 million investment and expansion in July, signaling a new era of unprecedented growth, including the establishment of a vaccine production facility.
The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.2 million men and women, contributes $2.32 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 63% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.
Market is currently valued at $770 million see more
Upsher-Smith Laboratories, LLC (Upsher-Smith) and AmbioPharm, Inc. (AmbioPharm) today announced that the companies have entered into a partnership agreement to develop and market Corticotropin Injection in the U.S. The market for adrenocorticotropic hormone or ACTH (brand Acthar® Gel*) is currently valued at $770 million (IQVIA, 12 months ending June 2020).
Under the terms of the agreement, Upsher-Smith will submit the New Drug Application for Corticotropin Injection to the U.S. Food and Drug Administration (FDA) and market and distribute it under its own label in the U.S. upon FDA approval. AmbioPharm will manufacture the active pharmaceutical ingredient exclusively for Upsher-Smith. A contract manufacturing organization will exclusively supply Upsher-Smith with the finished product for sale in the United States. Financial terms related to the deal have not been disclosed.
“We are excited to partner with AmbioPharm, a leader in the field of peptide development and manufacturing, to bring Corticotropin Injection to the U.S. market,” said Rusty Field, President and CEO of Upsher-Smith. “This agreement represents another step in Upsher-Smith’s and Sawai’s strategy to co-invest in highly complex generics and 505(b)(2) products that can drive long-term growth.”
Added Chris Bai, CEO of AmbioPharm, “We are pleased to bring our unsurpassed technical capabilities and peptide manufacturing capacity to our partnership with Upsher-Smith, a company with a long-standing tradition of bringing high-quality products to the patients who rely upon them.”
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. Since 1919, it has brought generics and brands to a wide array of customers backed by an attentive level of service, strong industry relationships, and dedication to uninterrupted supply.
As Upsher-Smith begins its second century in business, the company enters a new ambitious era that has been accelerated by its 2017 acquisition by Sawai Pharmaceutical Co., Ltd. Upsher-Smith and Sawai plan to leverage each other for growth worldwide and embark on an exciting new chapter as they seek to deliver the best value for their stakeholders, and most importantly, Do More Good™ for the patients they serve. For more information, visit www.upsher-smith.com.
AmbioPharm, Inc. is a full-service peptide manufacturing company headquartered at its North Augusta, South Carolina, USA cGMP production site. Its second cGMP facility in Shanghai, China, performs process development and optimization and manufactures building blocks, raw materials, and custom peptides at a very large scale. Both of its cGMP facilities are capable of handling any manufacturing scale required to produce bulk peptides to custom specifications using a wide range of skill sets in both solid and solution-phase chemistry. Its management team has over 120 years of cumulative experience running a pilot to commercial-scale production. The Company also performs organic conjugations to small molecules, proteins, toxoids, antifungals, KLH, and PEG. For more information, visit www.ambiopharm.com.
Milliken leveraging textile expertise in COVID fight see more
Milliken & Company, a global diversified manufacturer with more than 150 years of textile expertise, has invested significant resources to increase domestic production of its Milliken PerimeterTM advanced medical fabrics. Since March, the company has distributed more than 10 million yards of reusable medical fabrics in response to the global shortage of personal protective equipment (PPE). This recent inventory increase signals Milliken’s continued commitment to ensuring a sustainable, U.S.-based PPE supply chain.
Reusable medical textiles are ideal when cost is a driving factor and when single-use PPE supply is limited or unreliable. Garments made with Perimeter fabric can be laundered for safe reuse at least 25 times. The current demand for protective medical garments and the potential for shortages in the fall and winter prompted Milliken to prioritize production of the advanced material.
“Scaling up U.S. manufacturing of reusable protective fabrics protects the country’s PPE pipeline, which in turn protects more medical professionals,” said Chad McAllister, president of Milliken’s Textile Division and EVP, Milliken & Co. “These brave people have continued to care for us tirelessly, and we are committed to doing all we can to help keep them safe.”
Milliken’s durable Perimeter fabric is not only engineered for manufacturing Level 1 and 2 gowns for critical medical environments such as trauma centers but also provides a smart solution for other industries such as dental, educational and hospitality environments where advanced PPE is now important. The material’s ability to be used multiple times while maintaining a demonstrated protective barrier makes it a cost-effective, made-in-USA alternative to single-use PPE.
“An increasing number of industries and service providers are looking for American-made PPE solutions to protect their employees and customers. This demand highlights the critical need we noted earlier this year, specifically for the U.S. to have a stable PPE supply chain,” McAllister said. “Our goal at Milliken is to be part of the solution, so we’re proactively taking steps to help avoid another shortage of critical PPE.”
Milliken is collaborating with industry partners to ensure protective garments made with Milliken Perimeter fabric are available immediately across the country.
South Carolina Launches COVID-19 Emergency Supply Portal to Connect Providers with Organizations in NeedSouth Carolina launches portal to connect critical supplies with those who need them see more
SCMEP, South Carolina Hospital Association, SC Department of Commerce and SCBIO combine
to source critical medical supplies and get them to parties in need quickly
South Carolina – April 13, 2020 – A collaboration between SCMEP, the SC Hospital Association, the SC Department of Commerce and SCBIO has resulted in the expedited launch of a new online South Carolina Emergency Supply Collaborative web portal.
Located at www.SCCOVID19.org, the portal connects parties in need of essential supplies and equipment with those that can provide it in quickly and efficiently. It allows industry and community partners with the ability to quickly produce, source, test, certify or contribute critical medical supplies (such as face shields, gowns, ventilators and masks) to directly connect with the healthcare providers, first responders and members of industry in search of those essential supply needs in one easy step.
Manufacturers able to expand or pivot their production lines, suppliers and distributors with access to ready-made supplies, organizations able to donate supplies or personal protective equipment (PPE) can identify the supplies and equipment they can offer in the site’s central repository. Once quickly reviewed and vetted by a team from the collaborative, organizations in need of the materials will be digitally connected through the portal to secure their desired goods from providers directly.
The need for the portal was identified after members of the collaborative began individually fielding hundreds of calls from organizations in need of such supplies, said Chuck Spangler, President of the South Carolina Manufacturing Extension Partnership (SCMEP).
“Each of our respective organizations has strong and indelible positions as sources of information, connection and aid to our respective constituencies, so it was logical for those parties – whether hospitals or manufacturers, existing industry or life sciences organizations – to turn to us in time of need,” said Mr. Spangler. “After sharing among ourselves the flood of requests we were individually receiving and trying to manage, we determined that a combined approach would offer greatest value and efficiency for our state and its citizens, and the creation of the South Carolina COVID-19 Emergency Supply portal was quickly underway.”
The site identifies critical need items as evidenced by industry, healthcare, first responder and governmental audiences across the state, and allows organizations to quickly enter the type of goods they can provide or manufacture, quantities and production capacity, and supply chain needs or requirements. Once entered and vetted by the SCMEP team, inquiring parties seeking the goods will be connected to the providers through the portal. Organizations then conduct transactions and arrange and plan logistics directly.
“This is a joint effort to recruit community partners with ability to quickly source or provide needed medical supplies to support South Carolina’s COVID-19 response,” said Thornton Kirby, President and CEO of the SC Hospital Association. “South Carolina’s COVID-19 Emergency Supply website will save valuable time and effort in connecting those in need of goods with those who have them… at a time where every minute counts in saving lives and defeating this formidable virus.”
The COVID-19 Emergency Supply website will be updated constantly with new information and opportunities to support South Carolina emergency response efforts. It also links directly to individual websites of the four Collaborative partners, which each provide a host of resources, news, connections and relevant information for businesses and individuals.
“We are all in this together, and I am proud of the South Carolina business community’s continued response to serve our state during this unprecedented time,” said S.C. Secretary of Commerce Bobby Hitt. “The COVID-19 Emergency Supply Collaborative’s ability to connect manufacturers, suppliers and other organizations with the front-line medical personnel who need these critical items will serve as a valuable resource.”
Organizations and individuals can go online 24/7 to identify critical need items or to note what products they can provide or may need, said Sam Konduros, CEO of SCBIO. “We encourage every member of industry, if you have a product that is needed and which you can provide, produce, test, certify or donate, let us know that right now by completing the simple form on the site. And for organizations in need of such items, let us know that right away so that we can get connect you with parties who can help right now.”
Visit the new site at https://sccovid19.org/
Life sciences ecosystem growswith addition of Eclipse Automation in Rock Hill, SC see more
An automated system provider for the life sciences industry, Eclipse Automation, will invest $4.6 million in new operations in York County expected to create 90 jobs during the next five years.
Eclipse Automation, with locations in Canada and the U.S., supplies custom automated manufacturing equipment for the life sciences, energy, transportation, mining and telecommunications industries.
“The Rock Hill facility is the perfect location to support our long-term growth plan and ongoing commitment to our customers,” Eclipse Automation president and CEO Steve Mai said in a news release. “Eclipse is focused on delivering innovative automated solutions worldwide, and we believe that South Carolina has an impressive reputation in quality manufacturing and developing skilled resources. Both will provide a solid foundation for success at our new location.”
The renovated, 57,000-square-foot facility, located at 1510 Cedar Line Drive in Rock Hill, is projected to be operational in March.
For employment information, visit the company’s careers page.
“We are proud to welcome Eclipse Automation as they establish their new operations here in York County,” York County Council chair Michael Johnson said. “It is always exciting when a business of this caliber picks York County to call home.”
South Carolina life sciences gets another huge boost with BD's $150 million investment in Sumter see more
Medical technology company creating 125 new jobs
COLUMBIA, S.C. - BD (Becton, Dickinson and Company), a leading global medical technology company, today announced a $150 million investment in its existing Sumter County manufacturing facility. The company is projected to create an additional 125 new jobs over the next several years.
Employing more than 65,000 associates worldwide, BD is one of the world's largest medical technology companies and supports health care providers in more than 190 countries. BD's Sumter County facility has been in operation since 1970, manufacturing blood collection devices that are critical to the health care industry.
Located at 1575 Airport Road in Sumter, S.C., BD's Sumter facility is actively hiring for the new positions, and interested applicants should visit www.bd.com/careers for more information.
The Coordinating Council for Economic Development has approved job development credits related to this project, as well as a $600,000 Set Aside grant to assist with the costs of road work and site preparation.
"For nearly 50 years, BD's Sumter facility has consistently delivered superior quality products, vital for our customers and their patients, through a talented and engaged workforce. We would like to thank TheLINK economic development alliance, Sumter Economic Development, the City of Sumter, Sumter County and the S.C. Department of Commerce for their continued support of BD and our employees as we continue to invest in the facility. We look forward to the ongoing success of our BD Sumter manufacturing team as they continue to advance the world of health." -BD Executive Vice President of Global Operations and Chief Supply Chain Officer Jim Borzi
"After opening in our state more than 40 years ago, we're thrilled that BD continues to grow and succeed here. This announcement once again demonstrates that South Carolina is a place where medical technology companies want to do business, and we welcome this new $150 million investment." -Gov. Henry McMaster
"Not only does our state excel in advanced manufacturing, we're also increasingly a top choice for companies in the life sciences sector. BD has been a strong member of Team South Carolina for decades, and we congratulate them on their ongoing success." -Secretary of Commerce Bobby Hitt
"BD has been a leading employer in this county since opening its doors in 1970. We are grateful for their continued investment in our community and our people." -Sumter County Council Chairman James McCain
"We have long-enjoyed BD as a key component in the fabric of our industrial portfolio. This investment demonstrates their trust in our leadership, their commitment to the success of their business and their belief in our ability to regenerate the talent needed to produce the quality of goods for which BD is known." -Sumter Economic Development Chairman Greg Thompson
FIVE FAST FACTS
- BD is investing in its existing Sumter County manufacturing facility.
- $150 million investment to create 125 new jobs.
- Employing more than 65,000 associates worldwide, BD is one of the largest medical technology companies in the world and supports health care providers in more than 190 countries.
- Located at 1575 Airport Road in Sumter, S.C., BD's facility manufactures blood collection devices for the health care industry.
BD is actively hiring for the new positions, and interested applicants should visit www.bd.com/careers for more information.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit www.bd.com.
ZEUS Industrial has acquired MWC Technologies, LLC see more
ORANGEBURG, S.C., June 11, 2018 -- Zeus Industrial Products, Inc. (Zeus), a leading polymer extrusion manufacturer and material science innovator, today announced that it has acquired MWC Technologies, LLC (MWC). This adds to the capabilities that Zeus has been developing for the past five decades.
MWC, a manufacturer of medical device components based in Chattanooga, TN, possesses innovative technologies that support Zeus' growth strategy. This acquisition will allow for the global commercialization of the many cutting-edge, solution-driven products in MWC's portfolio.
Click to Tweet: @ZeusTubing acquires MWC Technologies: https://www.zeusinc.com/2018/06/11/zeus-acquires-mwc-technologies-llc/
"Since I founded the company in 1966, Zeus has been focused on continuing to grow and innovate. This acquisition supports those goals. We are confident that our acquisition of MWC will provide value to our customers today and into the future.." – Frank P. Tourville, Sr., Founder and Chairman of the Board, Zeus Industrial Products, Inc.
"The acquisition of MWC will expand our capabilities and product portfolio to address the rising demand for advanced precision extrusions. Our combined expertise will enhance our ability to better serve customers around the globe." – John Winarchick, CEO, Zeus Industrial Products, Inc.
"We are excited to be joining the Zeus team! Zeus's long term commitment to industry leading quality, customer service and innovation aligns well with MWC's culture. Our combined technologies will enable new to the market solutions for our customers." – Eric Avans, Quality Manager, MWC Technologies
Zeus Industrial Products: Learn more about the company and its products on the Zeus website; or call toll-free 1-800-526-3842 or +1-803-268-9500 outside the U.S.
ABOUT ZEUS INDUSTRIAL PRODUCTS, INC.
Zeus Industrial Products, Inc., is headquartered in Orangeburg, SC, USA. Its core business is the development and precision extrusion of advanced polymeric materials. The company employs over 1,500 people worldwide with manufacturing facilities in Aiken, Gaston and Orangeburg, South Carolina; Branchburg, New Jersey; and Letterkenny, Ireland. Zeus products and services serve companies in the medical, automotive, aerospace, fiber optics, energy and fluid management markets. For more information, visit www.zeusinc.com.
Lonza's $46 million investment expected to create new jobs in Greenwood, SC see more
Lonza, one of the world’s leading suppliers to the pharmaceutical, biotech and specialty ingredients markets, today announced plans to expand operations in Greenwood County. The company is investing $46 million over the next five years and is expected to generate 30 new jobs as a result.
Headquartered in Basel, Switzerland, Lonza harnesses science and technology to create products that enhance the overall quality of life for patients and consumers around the world. Through its acquisition of Capsugel in July 2017, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms.
Lonza’s Greenwood County operations, which are located at 535 North Emerald Road in Greenwood, S.C., produce empty capsules and finished dosage forms for the global biopharma and consumer health and nutrition markets. To expand, the company is adding approximately 50,000 square feet of new manufacturing space, which will enable the firm to produce key nutritional ingredients, among other projects.
With construction expected to be completed in the second quarter of 2019, hiring for the new positions will take place starting in mid-2018. Those interested in joining the Lonza team should visit the company’s careers page online(link is external).
The Coordinating Council for Economic Development has approved job development credits, as well as a $300,000 Set Aside grant to Greenwood County to assist with the costs of site work and infrastructure improvements.
“Lonza is making a significant investment in our operations in Greenwood, further demonstrating our commitment to providing high-quality products and services to our customers worldwide. Greenwood County is rich with talented, skilled individuals who will enhance our global and regional footprint, particularly in the area of consumer health and nutrition.” –Lonza Specialty Ingredients COO Sven Abend
“South Carolina’s workforce continues to demonstrate unmatched excellence; and, as a result, global companies like Lonza are growing and thriving here. I look forward to seeing all that these new positions will be able to produce and achieve in the years to come.” –Gov. Henry McMaster
“The Palmetto State’s life sciences industry continues to expand, showcasing South Carolina’s ability to produce a variety of advanced products. We congratulate Lonza and look forward to their continued success in Greenwood County.” –Secretary of Commerce Bobby Hitt
“Lonza has been an excellent job provider and a source of economic prosperity for Greenwood County. Their new expansion is exciting and encouraging, as it means their good work will continue to produce positive results for people locally and globally.” –Greenwood County Council Chairman Steve Brown
“We congratulate our friends at Lonza on today’s expansion announcement. Lonza’s continued growth within Greenwood County speaks to the company’s dedication and commitment to the area and the future of life sciences in South Carolina.” –Greenwood Partnership Alliance Chair Dr. Kristin Manske
FIVE FAST FACTS
- Lonza is expanding operations in Greenwood County.
- $46 million investment to create 30 new jobs.
- Lonza designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries.
- The company is adding 50,000 square feet to its Greenwood County facility, which is located at 535 North Emerald Road in Greenwood, S.C.
Avara Pharmaceutical Services finalizes acquisition of GSK Consumer Healthcare facility in South CarolinaAvara Pharmaceutical Services has completed a South Carolina acquisition from GSK see more
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization (CDMO), announced that the acquisition of the GlaxoSmithKline (GSK) consumer healthcare manufacturing facility in Aiken, South Carolina (USA) is complete. Read on for full details...
Accessible Diagnostics receives $250,000 SC Launch Investment see more
March 15, 2018 11:50 AM Eastern Daylight Time
SUMMERVILLE, S.C.--(BUSINESS WIRE)--SC Launch, Inc., SCRA’s entrepreneurial program, recently finalized a $250,000 investment for Accessible Diagnostics, a life science company based in Greenville, SC. The company was accepted as an SC Launch Client Company in December 2014 and received a $50,000 Acceleration Grant in June 2017.
Accessible Diagnostics is developing a smartphone-based, at-home health test platform in collaboration with healthcare professionals. Their first proprietary product, Vet-Tab, is a painless glucose test for a beloved family member, a diabetic dog. The investment will be used to finalize product development, manufacture the initial inventory and launch sales. The company has also begun the regulatory process to sell painless human glucose test.
“Concepts to Companies and accredited individuals provided the seed capital for Accessible Diagnostics to startup and reach this point,” said John Warner, Accessible Diagnostics CEO and Co-Founder. “We are grateful for Acceleration Grant last summer to help with prototype development and their investment this spring to help launch Vet-Tab sales.”
“Accessible Diagnostics can create enormous value by aggregating data to integrate into other digital heath platforms being created in the market,” said Director of Entrepreneurial Programs and SC Launch Inc. Executive Director, Jill Sorenson. “We are excited to see the growth of the company and the impact to South Carolina.”
SCRA is a state-chartered organization that fosters job creation and grows South Carolina’s Innovation Economy. The SC Launch program is SCRA’s entrepreneurial platform that provides mentoring, grants and investments to qualified, South Carolina companies in the Advanced Materials/Manufacturing, Information Technology and Life Sciences industries.
Chartered in 1983 by the State of South Carolina as a public, non-profit corporation, SCRA fosters South Carolina's Innovation Economy by supporting entrepreneurs, enabling academic research and its commercialization, and connecting industry to innovators.
Jessica Cokins, 843-760-3273
Polymer extrusion manufacturer ZEUS Industrial is creating more than 350 new jobs in South Carolina see more
COLUMBIA, S.C. – Zeus Industrial Products, Inc. (Zeus), a leading polymer extrusion manufacturer and material science innovator, is expanding its existing operations in Calhoun County. The company’s $76 million investment is expected to create an additional 350 jobs over the next several years.
Founded in 1966, Zeus develops and manufacturers polymer tubing for a variety of industries, including the medical, fluid handling and electrical markets. Zeus works with customers in collaborative relationships to design, engineer and produce fluoropolymer and specialized plastic tubing that delivers the temperature resistance, chemical resistance and high-tensile strength demanded by today’s applications.
The expansion will occur approximately two miles from Zeus’ existing Gaston, S.C. facility, located off of I-26 near Exit 119. When completed in 2019, the facility will contain approximately 148,000 square feet of manufacturing space. Hiring for the initial phase of new positions will begin during the first quarter of 2018. Interested applicants should visit the company’s careers page online(link is external) for more information.
The Coordinating Council for Economic Development has approved job development credits related to this project. A $1 million Rural Infrastructure Fund grant was also awarded to Calhoun County to assist with the costs of site preparation and building construction.
“We are truly excited about expanding our presence in Calhoun County. We have been pleased with all of the local and state support that we have received since commencing our Gaston operations back in 1996. We remain committed to being a good citizen of the county, meeting and exceeding the needs of our customers and, most importantly, providing quality careers for all of our employees in an atmosphere that will allow them to flourish.” –Zeus Industrial Products President and CEO John Winarchick
“Zeus has been a friend to South Carolina for decades, and we’re grateful for the continued commitment they’re showing to our people and the Calhoun County community by investing and creating more than 350 jobs there.” –Gov. Henry McMaster
“Zeus has been a longtime member of Team South Carolina, and I’m excited to see their operations grow once again. Over the last several decades, South Carolina has built an international reputation as a place that not only makes complex products, but makes them well. This announcement is a further testament to that.” –Secretary of Commerce Bobby Hitt
“It is always exciting when a business chooses to invest its dollars into Calhoun County, but when an existing industry with a long-term relationship in our county chooses to expand their operations, it is a cause for celebration. We are thrilled that Zeus’ footprint in Calhoun County will be growing, and we know their future endeavors will be successful. Calhoun County continues to provide low taxes, reasonable regulation and a business-friendly environment, making a fertile field ripe for new investments. We are proud to have Zeus as part of the Calhoun County industrial family!” –Calhoun County Council Chairman David K. Summers Jr.
“We congratulate Zeus on this outstanding announcement. Zeus’ decision to construct another facility in Calhoun County will provide hundreds of local workers with top-notch employment while expanding the visibility of a much-admired brand. Zeus’ continued growth and success in the region is something we look forward to celebrating for many years to come.” –Central S.C. Alliance Chairman Mike Brenan
FIVE FAST FACTS
- Zeus Industrial Products is expanding its Calhoun County operations.
- $76 million investment to create more than 350 new jobs.
- Zeus Industrial Products is a developer and manufacturer of fluoropolymer tubing for a variety of industries.
- When completed in late 2019, the facility will contain approximately 148,000 square feet of manufacturing space.
- Hiring for the initial phase of new positions should begin in the first quarter of 2018, and interested applicants should visit the company’s careers page online(link is external) for more information.
MED-ALLY is growing! The organization is locating new operations in South Carolina... see more
COLUMBIA, S.C. – MED-ALLY, a privately-held medical device manufacturer, is locating new operations in Berkeley County. The $2.38 million investment is expected to create 90 new jobs.
MED-ALLY is an innovative design, development and manufacturing company specializing in active implantable medical systems. The company has designed and developed VersaStim® neuromodulation platform technology, which treats patients with movement disorders, spinal cord injuries, chronic pain and traumatic brain injuries. The VersaStim® technology platform is available in external and implantable systems for clinicians to maximize therapy effectiveness and improve patient outcomes.
The company’s state-of-the-art, 10,000-square-foot manufacturing operation will be located in the Charleston International Manufacturing Center at 2040 Bushy Park Road in Goose Creek, S.C. An ISO Class 6 Clean Room, critical for the fabrication of implantable devices, will take up approximately half of the operating space. Expected to be fully operational in March 2018, MED-ALLY is already hiring for its new technical positions. Those interested in joining the team should visit www.med-ally.com(link is external).
The Coordinating Council for Economic Development has approved job development credits related to this project.
“We are indeed fortunate for the opportunity to join the many successful and class-leading companies that call the Lowcountry and Charleston home, and can only aspire to one day approach a close enough level of similar lofty accomplishments! Through the professional South Carolina organizations and wonderful associates at every level at the CRDA, SCRA, SCBIO, S.C. Commerce and others, more akin to treasured business partners over all else, we believe that we are surrounding ourselves with an enabling, empowering and conducive team like no other. We look forward to growing and prospering in Berkeley County amidst its wonderful constituency and leadership team.” –MED-ALLY, LLC CEO and Co-Founder Raja Edward Hitti
“We are excited to join the growing South Carolina medical device community and deliver innovative bioelectronic products that positively impact the global Healthcare market. The MED-ALLY team is looking forward to working with distinguished clinicians, university medical teams, industry partners and university students dedicated to providing disruptive medical device solutions to treat debilitated patients worldwide.” –MED-ALLY, LLC President and Co-Founder John Mulvihill
“It’s always exciting when a company decides to locate new operations in South Carolina, and we’re pleased to welcome such an innovative firm that’s focused on cutting-edge advanced manufacturing. I congratulate them on this new investment and can’t wait to see what the future has in store for them here.” –Gov. Henry McMaster
“The life sciences industry is one that presents significant growth opportunities for South Carolina, and today’s announcement by MED-ALLY is proof of that. I congratulate this innovative company and wish them much success in the Lowcountry.” –Secretary of Commerce Bobby Hitt
“MED-ALLY’s announcement of its medical device manufacturing project in the Lowcountry is extremely exciting for Berkeley County; we are honored to welcome MED-ALLY, their investment and the 90 technical jobs they offer. MED-ALLY’s announcement is also further proof that Berkeley County is open for business, and Berkeley County means business. Through meetings with the company’s team, I am confident MED-ALLY will thrive in Berkeley County and also be incredible partners in job creation opportunities for many years to come.” –Berkeley County Supervisor Bill Peagler
“We’ve been talking with MED-ALLY for some time about the competitive advantages the Charleston region offers, and we’re thrilled our community successfully competed against much larger U.S. metros to attract this implantable medical device manufacturer to locate its headquarters, R&D and manufacturing facility in Berkeley County. We are proud to welcome MED-ALLY to Charleston’s growing life sciences cluster. They will be a tremendous asset for many years to come.” –Charleston Regional Development Alliance Chairman Will Helmly
FIVE FAST FACTS
- MED-ALLY is locating new manufacturing operations in Berkeley County.
- $2.38 million investment to create 90 new jobs.
- MED-ALLY is a personalized health solutions company dedicated to manufacturing medical devices.
- Located at 2040 Bushy Park Road in Goose Creek, S.C., the company’s new facility is projected to be operational in March 2018.
- Those interested in joining the MED-ALLY team should visit www.med-ally.com(link is external).
Ritedose investing $10MM to expand in South Carolina see more
COLUMBIA, S.C. – The Ritedose Corporation, a pharmaceutical products manufacturer, is once again expanding its Richland County operations with a $10 million investment.
Ritedose, which specializes in the production of inhalation products, eye drops, ear drops and oral liquids, has operated at Carolina Research Park for more than 20 years. In 2014, it expanded its operations and now plans to do so again with a new 140,000-square-foot facility at the Enterprise Industrial Campus of Midlands Technical College. Owned by the college, the business park is a 150-acre property off Powell Road in northeast Columbia, S.C.
For more information on The Ritedose Corporation, visit www.ritedose.com(link is external).
“This new facility represents the Ritedose Corporation’s continued commitment to Richland County, and is indicative of the company’s mission of maintaining our position as a global market leader.” –Ritedose President and CEO Umesh Dalvi
“To see a company like Ritedose choose to continue investing in our state is an important sign to the business community around the world that South Carolina is the place to be. We look forward to seeing the new heights the relationship between our state and this company will reach in the years to come.” –Gov. Henry McMaster
“We’re excited to see the continued success of our state’s thriving life sciences industry. I offer my congratulations to Ritedose Corporation on this tremendous achievement and look forward to supporting them as they grow and prosper in our state.” –Secretary of Commerce Bobby Hitt
“The Ritedose Corporation’s decision to invest in Richland County is further evidence of the attributes of doing business in our community.” –Richland County Council Chair Joyce Dickerson
“Economic development and workforce development are the cornerstone of our mission at Midlands Technical College, and we are happy to partner with The Ritedose Corporation as they expand on our Enterprise Campus.” –Midlands Technical College President Dr. Ron Rhames
FIVE FAST FACTS
- Ritedose Corporation is constructing a new Richland County facility.
- $10 million investment.
- Ritedose is a manufacturer of pharmaceutical products.
- The company will be constructing a new 140,000-square-foot facility at Midlands Technical College’s Enterprise Industrial Campus off Powell Road in Columbia, S.C.
- For more information on The Ritedose Corporation, visit www.ritedose.com